AbbVie

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Allergan
gptkbp:acquisitionYear 2020
gptkbp:CEO gptkb:Richard_A._Gonzalez
gptkbp:countryOfOrigin gptkb:United_States
gptkbp:dividendPaying yes
gptkbp:founded 2013
gptkbp:foundedBy gptkb:Abbott_Laboratories
gptkbp:headquartersLocation gptkb:North_Chicago,_Illinois,_United_States
https://www.w3.org/2000/01/rdf-schema#label AbbVie
gptkbp:industry pharmaceuticals
gptkbp:ISIN US00287Y1091
gptkbp:marketCap over $250 billion (2024)
gptkbp:memberOf gptkb:S&P_500
gptkb:S&P_100
gptkbp:netIncome $4.87 billion (2023)
gptkbp:notable_executive gptkb:Azita_Saleki-Gerhardt
gptkb:Carlos_Alban
gptkb:Henry_O._Gosebruch
gptkb:Jeffrey_R._Stewart
gptkb:Laura_Schumacher
gptkb:Michael_E._Severino
gptkb:Nicholas_Donoghoe
gptkb:Robert_A._Michael
gptkb:Roopal_Thakkar
gptkb:Thomas_C._Hudson
gptkb:Timothy_J._Richmond
gptkb:William_J._Chase
gptkbp:notablePatentLitigation Humira biosimilars
gptkbp:notableProduct gptkb:Humira
gptkb:Imbruvica
gptkb:Rinvoq
gptkb:Skyrizi
gptkb:Venclexta
gptkbp:numberOfEmployees ~50,000
gptkbp:parentCompany none
gptkbp:researchFacilityLocation gptkb:Redwood_City,_California,_United_States
gptkb:Worcester,_Massachusetts,_United_States
gptkb:Ludwigshafen,_Germany
gptkb:Lake_County,_Illinois,_United_States
gptkbp:revenue $58.05 billion (2023)
gptkbp:SIC 2834
gptkbp:spinOff gptkb:Abbott_Laboratories
gptkbp:stockSymbol gptkb:NYSE
gptkb:ABBV
gptkbp:therapeuticArea aesthetics
immunology
neuroscience
oncology
gastroenterology
virology
eye care
gptkbp:tradedOn gptkb:NYSE
gptkbp:website https://www.abbvie.com/
gptkbp:bfsParent gptkb:Caribou_Biosciences
gptkb:Cystic_Fibrosis_Foundation
gptkb:Infinity_Pharmaceuticals
gptkb:Ironwood_Pharmaceuticals
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
gptkb:NOVN
gptkbp:bfsLayer 5